|
ACTR6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.43970000000093E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.498000E-03 |
| Normal-vs-Stage2 |
2.406400E-01 |
| Normal-vs-Stage3 |
4.85999999999542E-06 |
| Normal-vs-Stage4 |
9.27690000041004E-07 |
| Stage1-vs-Stage2 |
7.247200E-01 |
| Stage1-vs-Stage3 |
1.768100E-02 |
| Stage1-vs-Stage4 |
1.078290E-02 |
| Stage2-vs-Stage3 |
1.609770E-01 |
| Stage2-vs-Stage4 |
1.449620E-01 |
| Stage3-vs-Stage4 |
9.639400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.51730000000195E-05 |
| Normal-vs-AfricanAmerican |
3.186100E-04 |
| Normal-vs-Asian |
2.868100E-02 |
| Caucasian-vs-AfricanAmerican |
6.042400E-01 |
| Caucasian-vs-Asian |
3.255800E-01 |
| AfricanAmerican-vs-Asian |
6.332800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.30709999999856E-05 |
| Normal-vs-Female |
7.814600E-04 |
| Male-vs-Female |
4.788000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.037740E-03 |
| Normal-vs-Age(41-60Yrs) |
8.967000E-04 |
| Normal-vs-Age(61-80Yrs) |
1.619350E-04 |
| Normal-vs-Age(81-100Yrs) |
1.737840E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.364200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.296800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.177800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.177800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.186400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.254400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.054000E-01 |
| Normal-vs-Grade 2 |
1.076960E-01 |
| Normal-vs-Grade 3 |
8.71809957558867E-10 |
| Normal-vs-Grade 4 |
2.43660003285129E-09 |
| Grade 1-vs-Grade 2 |
3.882400E-01 |
| Grade 1-vs-Grade 3 |
3.518600E-03 |
| Grade 1-vs-Grade 4 |
1.164390E-03 |
| Grade 2-vs-Grade 3 |
3.99039999999795E-05 |
| Grade 2-vs-Grade 4 |
1.28820000000474E-06 |
| Grade 3-vs-Grade 4 |
3.745600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.982200E-01 |
| Normal-vs-ccB subtype |
6.7135999981538E-08 |
| ccA subtype-vs-ccB subtype |
2.00409999999707E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.619800E-04 |
| Normal-vs-N1 |
2.063000E-03 |
| N0-vs-N1 |
3.528000E-01 |
|
|
